PIC is among the first to receive approval for the use of gene editing in commercial livestock in the U.S.

Today the U.S. Food and Drug Administration (FDA) announced it has granted approval to PIC for the gene edit used in its PRRS-resistant pig, determining that the technology is safe and effective. This is a landmark approval, as PIC becomes among the first companies to gain approval for gene editing in commercial livestock in the U.S.